FDA Adverse Event Injury Summary report: N

JUVEDERM ULTRA PLUS

MDR report key: 1192116 · Received October 7, 2008

Report

Report Number
3005113652-2008-00061
Event Type
Injury
Date Received
October 7, 2008
Date of Event
August 21, 2008
Report Date
August 21, 2008
Manufacturer
PRINGY
Product Code
LMH
PMA / PMN Number
P050047
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

A DAY AFTER TREATMENT WITH JUVEDERM ULTRA PLUS IN THE NASOLABIAL FOLDS, THE PT AWOKEN TO A HEADACHE AND PAIN IN THE SCALP AREA, AS WELL AS DISCOMFORT SLIGHTLY ABOVE THE INJECTION SITE. THE PT ALSO EXPERIENCED SYMPTOMS OF EDEMA AND BRUISING AT THE INJECTION SITE. THE PT TOOK IBUPROFEN THAT HELPED WITH THE PAIN, BUT THAT WAS NOT PRESCRIBED. THE PHYSICIAN PRESCRIBED A MEDROL DOSEPAK (ROUTE: "PO") AND BELIEVES THAT IF TREATMENT WAS NOT GIVEN THEN THERE MAY BE HAVE BEEN WORSENING OF SYMPTOMS LEADING TO PERMANENT DAMAGE. ALL THE SYMPTOMS HAVE NOW RESOLVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 JUVEDERM ULTRA PLUS JUVEDERM LMH PRINGY NA HV30244057

Patients

Seq Age Sex Outcome Treatment
1 NI Required Intervention